Ramírez AS

Language: Spanish
References: 6
Page: s57-59
PDF size: 119.52 Kb.

REFERENCES

1. Arroyo-Pérez JA, Ramírez-Arcos S, Trejo Gómora JE. Guía de control de calidad microbiológico de componentes plaquetarios para incrementar la seguridad en su uso clínico en México. Centro Nacional de la Transfusión Sanguínea, September 10, 2020. V1.0. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/577062/Gu_a_plaquetas_2020_formato.pdf?fbclid=IwAR1dBu-ZRzdO0BSShfYVgXlmXRUbdXjFBV2Ww6o01oeBLEUBq0pn7o9ifKM

2. Ramirez-Arcos S, Evans S, McIntyre T, Pang C, Yi QL, DiFranco C et al. Extension of platelet shelf life with an improved bacterial testing algorithm. Transfusion. 2020; 60 (12): 2918-2928.

3. Kamel H, Ramirez-Arcos S, McDonald C; ISBT Transfusion-transmitted infectious disease bacterial working party bacterial subgroup. The international experience of bacterial screen testing of platelet components with automated microbial detection systems: an update.Vox Sang. 2022; 117: 647-655. doi: 10.1111/vox.13247.

4. Schmidt M, Ramirez-Arcos S, Stiller L, McDonald C; ISBT transfusion-transmitted infectious diseases working party, subgroup on bacteria. Vox Sang. 2022; 117 (8): 983-988. doi: 10.1111/vox.13283.

5. Cloutier M, De Korte D, ISBT Transfusion-transmitted infectious diseases working party, subgroup on bacteria. Residual risks of bacterial contamination for pathogen-reduced platelet components. Vox Sang. 2022; 117 (7): 879-886. doi: 10.1111/vox.13272.

6. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. Guidance for Industry, December 2020. Available in: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bacterial-risk-control-strategies-blood-collection-establishments-and-transfusion-services-enhance